The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Adjuvant chemotherapy guided by circulating tumor DNA analysis in stage II colon cancer: The randomized DYNAMIC Trial.
 
Jeanne Tie
Honoraria - Inivata; SERVIER
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Haystack Oncology; Inivata; MSD Oncology; Pierre Fabre
 
Joshua Cohen
Consulting or Advisory Role - Haystack Oncology
Patents, Royalties, Other Intellectual Property - Haystack Oncology
 
Kamel Lahouel
No Relationships to Disclose
 
Serigne N. Lo
No Relationships to Disclose
 
Yuxuan Wang
Patents, Royalties, Other Intellectual Property - U.S. Patent UA2015/0292027: Papanicolaou Test for Ovarian and Endometrial Cancers.; U.S. Patent US2018/0171413: Detection of Tumor-Derived DNA in Cerebrospinal Fluid.; U.S. Patent US2018/0171413: Detection of Tumor-Specific DNA in Saliva and Blood.; U.S. Patent US2018/0258490: Diagnostic Potential of Tumor DNA from Ovarian Cyst Fluid.; U.S. Patent US2018/045669: Methods and Materials for Assessing and Treating Cancer.; U.S. Patent US2018/045669: Methods and Materials for Assessing and Treating Cancer.
 
Rachel Wong
No Relationships to Disclose
 
Jeremy David Shapiro
No Relationships to Disclose
 
Samuel J. Harris
No Relationships to Disclose
 
Muhammad Adnan Khattak
No Relationships to Disclose
 
Matthew E. Burge
Stock and Other Ownership Interests - Bristol-Myers Squibb; coclear; CSL Limited; Gilead Sciences; pfizer
Honoraria - Amgen; Bristol Myers squibb; Merck KGaA; Merck Sharp & Dohme; SERVIER
Consulting or Advisory Role - Amgen; ipsen; merck srpe Dohme; Roche; SERVIER
Speakers' Bureau - Merck Sharpe Dohme
Research Funding - Amgen (Inst)
Patents, Royalties, Other Intellectual Property - funding for an investigator initiated prospective trial (Inst)
 
Marion Harris
No Relationships to Disclose
 
James F. Lynam
Employment - Precision for Medicine
Leadership - Healthscope Advanced Pathology
Consulting or Advisory Role - Merck Serono (Inst)
Speakers' Bureau - AstraZeneca; Ipsen
 
Louise M. Nott
Honoraria - Amgen (Inst); Merck Serono; Merck Sharp & Dohme
Consulting or Advisory Role - Pfizer
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Novartis; Novartis; Roche
 
Fiona Day
No Relationships to Disclose
 
Theresa Hayes
No Relationships to Disclose
 
Nickolas Papadopoulos
Leadership - Haystack Oncology; Thrive Earlier Detection Corp
Stock and Other Ownership Interests - Cage Pharma; Haystack Oncology; ManaT Bio; NeoPhore; Personal Genome Diagnostics; Thrive Earlier Detection Corp
Patents, Royalties, Other Intellectual Property - Haystack Oncology; NeoPhore; Personal Genome Diagnostics; Thrive Earlier Detection Corp
 
Cristian Tomasetti
Stock and Other Ownership Interests - Thrive Earlier Detection Corp
Consulting or Advisory Role - Bayer; PrognomIQ
Patents, Royalties, Other Intellectual Property - Exact Sciences
 
Kenneth W. Kinzler
Leadership - Haystack Oncology; Thrive Earlier Detection Corp
Stock and Other Ownership Interests - CAGE Pharma; Exact Sciences/Thrive Earlier Detection; Haystack Oncology; ManaT Bio; Neophore; Personal Genome Diagnostics
Consulting or Advisory Role - Cage Pharma; Exact Sciences/Thrive Earlier Detection; Haystack Oncology; ManaT Bio; Neophore; Personal Genome Diagnostics
Patents, Royalties, Other Intellectual Property - I receive royalties for intellectual property owned and managed by Johns Hopkins University.
 
Bert Vogelstein
Leadership - Thrive Earlier Detection Corp
Stock and Other Ownership Interests - Cage Pharma; Exact Sciences; Haystack Oncology; ManaT Bio; NeoPhore; Personal Genome Diagnostics
Consulting or Advisory Role - Cage Pharma; Exact Sciences; Haystack Oncology; ManaT Bio; NeoPhore; Personal Genome Diagnostics
Patents, Royalties, Other Intellectual Property - Haystack Oncology; Thrive Earlier Detection Corp
 
Peter Gibbs
Honoraria - Amgen; Merck; MSD Oncology; Roche; SERVIER
Consulting or Advisory Role - Haystack Oncology
Research Funding - Amgen (Inst); Bayer (Inst); Bristol-Myers Squibb/Sanofi (Inst); Merck Serono (Inst); Pierre Fabre (Inst); Roche (Inst); Roche Molecular Diagnostics (Inst); Servier (Inst)
Travel, Accommodations, Expenses - Servier